Accessibility Menu
Imac logo

Imac(NASDAQ) IMAC

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-100%
5 Year-100%
1 Year-99%
1 Month+150%
N/A
Imac last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-28
Imac stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-08-21
1 month+150%USD 0.002026-07-29
3 month-98.89%USD 0.052026-05-29
Year to date-99.64%USD 0.142025-12-31
1 year-99.29%USD 0.072025-08-28
3 year-99.98%USD 2.942023-08-29
5 year-100%USD 44.402021-08-27
Since inception-100%USD 110.402019-02-13

Imac Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

-$5.02M

Net Income (TTM)

-$9.28M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Aug 15, 2022

IMAC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Imac

IMAC Holdings, Inc. operates a network of advanced medical and regenerative care centers across the United States. The company specializes in innovative regenerative, orthopedic, and minimally invasive therapies aimed at treating various conditions, including athletic injuries and chronic pain.

Products and Services
  • Outpatient clinics offering regenerative and orthopedic therapies
  • Physical therapy and chiropractic manipulation services
  • Minimally invasive treatments for chronic pain and injuries
Growth Outlook
  • Expansion into new markets with 15 facilities across multiple states
  • Increasing demand for regenerative therapies in healthcare
  • Focus on innovative treatment options to attract more patients
Financial Highlights
  • Recent quarterly revenue of $21,223, indicating potential growth
  • Trailing twelve months (TTM) net income shows significant losses
  • Operating expenses have increased, impacting profitability
IMAC Holdings, Inc. is positioned in the healthcare sector, focusing on outpatient services that cater to a growing demand for advanced medical treatments. The company operates 15 facilities across states like Kentucky, Missouri, and Florida, which allows for a broad reach in the market. The increasing interest in regenerative therapies presents a significant opportunity for growth, as more patients seek alternatives to traditional treatments. Recent financial data indicates a quarterly revenue of $21,223, which, while modest, reflects the company's ongoing operations. However, the trailing twelve months (TTM) data reveals substantial losses, highlighting the challenges faced in achieving profitability. Operating expenses have risen, which may affect future financial performance. Despite these challenges, the company's focus on innovative treatment options and expansion into new markets could provide a pathway to improved financial health in the long term.
AI Generated • Aug 23, 2026

Industry

Healthcare Providers and Services

Employees

15

CEO

Faith Zaslavsky

Headquarters

Brentwood, TN 37027, US

IMAC Financials

Key Financial Metrics (TTM)

Gross Margin

-1349.60%

Operating Margin

-26468.83%

Net Income Margin

-32560.25%

Return on Equity

72.93%

Return on Capital

N/A

Return on Assets

-2386.24%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

-2.93%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

-$1.56M

Operating Income

-$1.80M

EBITDA

-$2.59M

Operating Cash Flow

-$519.87M

Capital Expenditure

$474.14K

Free Cash Flow

-$519.40M

Cash & ST Invst.

$45.05K

Total Debt

$0.00

Imac Performance Analysis

Imac annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 14,385,828N/A
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 72,050N/A
Imac sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31N/A
Q12025-03-31100.0%
Q22025-06-30-100.0%
Q32025-09-30N/A
Imac annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -14.02N/A
20222022-12-31USD -458.193167.2%
20232023-12-31USD -7.48-98.4%
20242024-12-31USD -7.702.9%
Imac sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31N/A
Q12025-03-31-1442.9%
Q22025-06-3017.6%
Q32025-09-30-29.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$21.22K

-99.6%

Gross Profit

-$102.65K

-108.2%

Gross Margin

-4.84%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

154

N/A

Net Income

-$3.08M

-262.8%

EBITDA

$52.19K

+103.7%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Total Cash

$45.05K

-100.0%

Total Debt

$0.00

-100.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-23.86%

N/A

Return on Invested Capital

46.35%

N/A

Free Cash Flow

-$1.42M

-100.3%

Operating Cash Flow

-$1.42M

-100.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GRCEGrace Therapeutics, Inc.
$2.13-0.23%
IRDOpus Genetics, Inc.
$3.70+2.07%
SHLTSHL Telemedicine Ltd.
$2.05+0.99%
AKLIAkili, Inc.
$0.43+0.25%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$218.58-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.48-0.05%
BIAFbioAffinity Technologies
$6.34+0.39%
INTCIntel
$88.96-0.01%

Questions About IMAC

What is the current price of Imac?

Imac is trading at N/A per share.

What is the 52-week range for Imac?

Over the past 52 weeks, Imac has traded between N/A and N/A.

How much debt does Imac have?

As of the most recent reporting period, Imac reported total debt of $3.83M.

How much cash does Imac have on hand?

Imac reported $45.05K in cash and cash equivalents in its most recent financial results.

What is Imac’s dividend yield?

Imac does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.